Linjie Zhang

Linjie Zhang

Auto-generated profile, based on publicly available information

Linjie Zhang

Faculdade de Medicina Universidade Federal do Rio Grande ‐ FURG Rio Grande Brazil

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2014 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
ABAlessandra Monteiro Brodt
Alessandra Monteiro Brodt
ESElizabeth Stovold
Elizabeth Stovold
LZLinjie Zhang
Linjie Zhang
We conducted a meta-analysis of randomised trials to evaluate the efficacy and safety of inhaled antibiotics in patients with stable non-cystic fibrosis (CF) bronchiectasis.We searched the Cochrane Airways Group Register of Trials from inception until March 2014.12 trials with 1264 adult patients were included, of which five were unpublished studies. Eight trials on 590 patients contributed data to the meta-analysis. Amikacin, aztreonam, ciprofloxacin, gentamicin, colistin or tobramycin were used for 4 weeks to 12 months. Inhaled antibiotics were more effective than placebo or symptomatic treatment in reducing sputum bacterial load (five trials; weighted mean difference −2.65 log10CFU·g−1, 95% CI -4.38– -0.92 log10CFU·g−1), eradicating the bacteria from sputum (six trials; risk ratio 4.2, 95% CI 1.66–10.64) and reducing the risk of acute exacerbations (five trials; risk ratio 0.72, 95% CI 0.55–0.94). Bronchospasm occurred in 10% of patients treated with inhaled antibiotics compared with 2.3% in the control group (seven trials; risk ratio 2.96, 95% CI 1.30–6.73), but the two groups had the same withdrawal rate due to adverse events (12.2%).Inhaled antibiotics may provide an effective suppressive antibiotic therapy with an acceptable safety profile in adult patients with stable non-CF bronchiectasis and chronic bronchial infection.

8 October 2008
Verified
Reference Entry
Closed access
PDF file
LZLinjie Zhang
Linjie Zhang
RMRaúl A Mendoza-Sassi
Raúl A Mendoza-Sassi
CWClaire Wainwright
Claire Wainwright
TKTerry P Klassen
Terry P Klassen

31 July 2013 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
LZLinjie Zhang
Linjie Zhang
RMRaúl A Mendoza-Sassi
Raúl A Mendoza-Sassi
CWClaire Wainwright
Claire Wainwright
TKTerry P Klassen
Terry P Klassen

1 May 2000 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
LZLinjie Zhang
Linjie Zhang
KIKlaus Irion
Klaus Irion
HKHarry Kozakewich
Harry Kozakewich
LRLynne Reid
Lynne Reid
JCJosé J. Camargo
José J. Camargo
FSFernando Abreu e Silva
Fernando Abreu e Silva

17 September 2014 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
LZLinjie Zhang
Linjie Zhang
SPSílvio O M Prietsch
Sílvio O M Prietsch
IAInge Axelsson
Inge Axelsson
SHScott A Halperin
Scott A Halperin

1 March 2018 in European Journal Of Dermatology
Verified
Journal Article
Closed access
ESElizabet Saes-Silva
Elizabet Saes-Silva
RTRoberto Tavares
Roberto Tavares
FPFelipe da Silva Paulitsch
Felipe da Silva Paulitsch
LZLinjie Zhang
Linjie Zhang
The use of sunscreen is a key component of public health campaigns for skin cancer prevention, but epidemiological studies have raised doubts on its effectiveness in the general population. This systematic review and meta-analysis aimed to assess the association between risk of skin cancer and sunscreen use. We searched PubMed, BIREME and Google Scholar from inception to May 17, 2017, to identify observational studies and controlled trials. We used a random-effects model for conventional and cumulative meta-analyses. We included 29 studies (25 case-control, two cohort, one cross-sectional, and one controlled trial) involving 313,717 participants (10,670 cases). The overall meta-analysis did not show a significant association between skin cancer and sunscreen use (odds ratio (OR) = 1.08; 95% CI: 0.91-1.28, I2 = 89.4%). Neither melanoma (25 studies; 9,813 cases) nor non-melanoma skin cancer (five studies; 857 cases) were associated with sunscreen use, with a pooled OR (95% CI) of 1.10 (0.92-1.33) and 0.99 (0.62-1.57), respectively. The cumulative evidence before the 1980s showed a relatively strong positive association between melanoma and sunscreen use (cumulative OR: 2.35; 95% CI: 1.66-3.33). The strength of the association between risk of skin cancer and sunscreen use has constantly decreased since the early 1980s, and the association was no longer statistically significant from the early 1990s. While the current evidence suggests no increased risk of skin cancer related to sunscreen use, this systematic review does not confirm the expected protective benefits of sunscreen against skin cancer in the general population.